ArticleScientific reports2025
Monte Carlo simulation of a novel medical linac concept for highly conformal x-ray FLASH cancer radiotherapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A beam model and Boltzmann solver for radiotherapy treatment planning of superficial brain metastases using a scanned electron beam at ultra-high (FLASH) dose rate.Physics in medicine and biology · 2026Article
- Ultra-intense pulsed source of ionizing radiation based on direct laser acceleration of electrons for studying the FLASH effect.Scientific reports · 2026Article
- FLASH Radiotherapy in Lung Cancer: Translational Mechanisms, Preclinical Evidence, and Barriers.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A growing body of pre-clinical research has demonstrated the potential of ultra-high dose-rate (UHDR) radiotherapy to reduce normal tissue toxicity while maintaining tumor control. However, owing to a wide range of technical difficulties, no existing x-ray systems are capable of highly conformal UHDR radiotherapy to humans. In this work, we designed and simulated a novel x-ray UHDR system representing a next-generation solution for rapid and highly conformal treatment delivery. This system comprises 16 stationary beamlines employing a new class of highly efficient linear accelerator to generate 12 MeV electron beams electromagnetically steered onto a bremsstrahlung target, a collimator with channels to create a divergent array of x-ray beamlets, and a translating patient couch. The system design was tuned to maximize the dose rate while minimizing beam penumbra and cross-channel leakage. A simulation framework was developed to facilitate iteration of machine parameters during optimization. A treatment plan for a case of locally advanced lung cancer was generated using an in-house optimizer to assess the capabilities of the x-ray UHDR system. Individual beamlets of 10, 15, and 20-mm in size can produce isocenter dose rates of 17.3, 18.7, and 19.7-Gy/mAs and cross-channel leakage of 2.3, 1.9, and [Formula: see text], respectively. The novel UHDR 10-Gy/fraction plan exhibited comparable or improved conformity, homogeneity, and mean dose to organs at risk compared to the clinically used plan and it was delivered in 500 ms with more than [Formula: see text] of target volume receiving local dose rates higher than 40Gy/s.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.